Unpaid liabilities assumed in connection with Merger Unpaid Liabilities Assumed in Connection with Merger Amount of unpaid liabilities assumed in connection with Merger. Business Acquisition [Axis] Business Acquisition [Axis] Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Related Party Transactions [Abstract] Principal amount of SVB loan payable Long-Term Debt, Gross Proceeds from maturity of short-term investments (certificates of deposit) Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Entity Address, Postal Zip Code Entity Address, Postal Zip Code Finance lease right-of-use assets, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Property, Plant and Equipment [Abstract] Minimum fixed rate on variable rate Debt Instrument, Interest Rate, Minimum Fixed Rate On Variable Rate Debt Instrument, Interest Rate, Minimum Fixed Rate On Variable Rate Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Short-term investments (certificates of deposit) Investments, Fair Value Disclosure Contingent Earnout Liability Business Combinations Policy [Policy Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Property and equipment, gross Property, Plant and Equipment, Gross Related party expenses Related Party Transaction, Expenses from Transactions with Related Party Income Taxes Income Tax Disclosure [Abstract] Warrants immediately exercisable (in shares) Class of Warrant or Right, Warrants Exercisable Immediately Represents the number of warrants immediately exercisable. Change in fair value included in other income, net Contingent Earnout Liability Contingent Earnout Liability [Member] Represents the information pertaining to contingent earnout liability. Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Financing transaction Proceeds from Issuance or Sale of Equity Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Series D preferred stock Series D Preferred Stock [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation expense Depreciation License Agreement License Agreement [Member] Represents the pertaining information to license agreement. Proceeds from debt instruments Proceeds from Issuance of Debt Proceeds from the exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Accrued interest on PPP loan obligation Interest Expense, Debt, Excluding Amortization Yale University Yale University [Member] Represents the information pertaining to yale university. Share-Based Payment Arrangement [Abstract] Asset Acquisition [Table] Asset Acquisition [Table] Collaborative Arrangement, Milestone Payments [Axis] Collaborative Arrangement, Milestone Payments [Axis] Collaborative Arrangement, Milestone Payments Founder shares converted to common stock (in shares) Shares acquired (in shares) Stock Issued During Period, Shares, Acquisitions Debt Instrument, Prepayment Fee, Period One Debt Instrument, Prepayment Fee, Period One [Member] Debt Instrument, Prepayment Fee, Period One Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding Net income (loss) Net income (loss) Net income (loss) attributable to common shareholders Net Income (Loss) Attributable to Parent Measurement Input Type [Domain] Measurement Input Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Securities that were not included in the computation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Information [Line Items] Document Information [Line Items] Summary of Future Minimum Payments of Principal Schedule of Maturities of Long-Term Debt [Table Text Block] Equity Component [Domain] Equity Component [Domain] Total financial assets Assets, Fair Value Disclosure Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Founder shares conversion ratio Reverse Recapitalization, Founder Shares Conversion, Ratio The ratio of the conversion of founder shares to common stock upon closing of business combination. Amortization expense Finance Lease, Right-of-Use Asset, Amortization Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Other Other Related Party Expenses [Member] Represents the information pertaining to other research and development expenses. Number of days warrants become exercisable after the completion of merger Number of Days Warrants Become Exercisable After the Completion of Merger The number of days warrants become exercisable after the completion of merger. Estimated dividend yield Measurement Input, Expected Dividend Rate [Member] Supplemental disclosure Supplemental Cash Flow Information [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Debt Instrument, Prepayment Fee, Period [Domain] Debt Instrument, Prepayment Fee, Period [Domain] Debt Instrument, Prepayment Fee, Period [Domain] Number of operating segments Number of Operating Segments Plan Name [Domain] Plan Name [Domain] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] ESPP Employee Stock [Member] Weighted average remaining contractual term, outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Contingent Consideration Tranches [Axis] Contingent Consideration Tranches [Axis] Represents the contingent consideration tranches number. Award Type [Axis] Award Type [Axis] Contingent Consideration by Type [Domain] Contingent Consideration Type [Domain] Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating lease obligation, current portion Operating Lease, Liability, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Related Party Transaction [Domain] Related Party Transaction [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Private Placement Warrants Private Placement Warrants [Member] Represents the information pertaining to private placement warrants. Lender Name [Axis] Lender Name [Axis] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Liability Class [Axis] Liability Class [Axis] Legal Entity [Axis] Legal Entity [Axis] SVB loan payable, noncurrent portion Long-Term Debt, Excluding Current Maturities Cash equivalents (certificates of deposit) Certificates of Deposit [Member] Total liabilities Liabilities Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Number of tranches of contingent earnout shares Reverse Recapitalization, Contingent Consideration, Liability, Number of Tranches The number of tranches of shares of combined entity that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Humacyte, Inc. Humacyte, Inc. [Member] Represents Humacyte, Inc. Redeemable convertible preferred Stock Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding BVP Patent Rights BVP Patent Rights [Member] BVP Patent Rights Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fresenius Medical Care Fresenius Medical Care [Member] Represents information pertaining to Fresenius Medical Care. Scientific Equipment, Not Placed Into Service Scientific Equipment, Not Placed Into Service [Member] Scientific Equipment, Not Placed Into Service Scientific equipment Scientific Equipment [Member] N/A Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Collaborative Arrangement, Milestone Payments [Domain] Collaborative Arrangement, Milestone Payments [Domain] Collaborative Arrangement, Milestone Payments [Domain] Assets: Assets, Fair Value Disclosure [Abstract] Debt Debt Disclosure [Text Block] Shares issued under agreement (in shares) Collaborative Arrangement, Shares Issued Represents the number of shares issued in connection with License agreement. Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Accrued expenses Increase (Decrease) in Accrued Liabilities Concentration Risk [Table] Concentration Risk [Table] Number of securities issued or issuable (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Earnout Shares Earnout Shares [Member] Earnout Shares 2025 Long-Term Debt, Maturity, Year Three Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Transaction costs recorded in APIC Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Fair Value per share on Closing Date (in dollars per share) Fair Value per Share on Closing Date Fair value per share on closing date. Issuance of options under stock plans Issuance of options under stock plan [Member] Represents the information on issuance of options under stock plan. Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Total assets Assets Debt Disclosure [Abstract] Business Acquisition, Contingent Consideration [Line Items] Business Acquisition, Contingent Consideration [Line Items] Income Statement Location [Axis] Income Statement Location [Axis] Expiration period of agreement Collaborative Arrangement, Expiration Period Represents the agreement expiration term after first commercial sale. Assumptions on the date of grant to estimate the fair value of the stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued expenses Total Accrued Liabilities, Current Credit Concentration Risk Credit Concentration Risk [Member] Less SVB loan payable, current portion Long-Term Debt, Current Maturities Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Stockholders' Equity Note [Abstract] Accrued employee compensation and benefits Employee-related Liabilities, Current Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Amount that will be eligible to disburse per tranche Debt Instrument, Unused Borrowing Capacity, Amount per Tranche Debt Instrument, Unused Borrowing Capacity, Amount per Tranche Stockholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Schedule of Assumptions Used to Estimate Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Finance lease obligation, net of current portion Finance Lease, Liability, Noncurrent Operating lease obligation Increase (Decrease) in Operating Lease Liability Related Party Transaction [Line Items] Related Party Transaction [Line Items] Accelerated vesting ending period Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting Ending Period Represents the end of involuntary termination term after effective date of corporate transaction. Short-term Investments Short-Term Investments [Member] Award Type [Domain] Award Type [Domain] Expected weighted average period compensation costs to be recognized (years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Gain on PPP loan forgiveness Gain on PPP loan forgiveness Gain (Loss) on Extinguishment of Debt Weighted average remaining contractual term, vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term AHAC Founders AHAC Founders [Member] AHAC Founders Series C preferred stock Series C Preferred Stock [Member] Computer equipment Computer Equipment [Member] Maximum contingent earnout (in shares) Reverse Recapitalization, Contingent Consideration, Liability, Shares The maximum aggregate number of shares of combined entity that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Entity Registrant Name Entity Registrant Name New Humacyte shares issued to PIPE Investors (in shares) Stock Issued During Period, Shares, New Issues Closing stock price to trigger contingent earnout shares (in dollars per share) Reverse Recapitalization, Contingent Consideration, Liability, Per Share Reverse Recapitalization, Contingent Consideration, Liability, Per Share Merger Agreement Merger Agreement [Member] Merger Agreement Estimated dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Software Software Development [Member] Entity Address, City or Town Entity Address, City or Town Accelerated vesting commencement period Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting Commencement Period Represents the commencement of involuntary termination term prior to effective date of corporate transaction. Operating expenses: Operating Expenses [Abstract] Expected term Measurement Input, Expected Term [Member] Tubular Prostheses Patent Rights Tubular Prostheses Patent Rights [Member] Tubular Prostheses Patent Rights SVB Loan payable SVB Loan Payable [Member] Represents information pertaining to SVB loan payable. Grant revenue Revenue Not from Contract with Customer Minimum Minimum [Member] Distribution agreement, termination period Distribution Agreement, Termination Period Distribution Agreement, Termination Period Issuance of warrants in conjunction with debt Issuance of Stock Warrants in Conjunction with Debt Represents the issuance of stock warrants in conjunction with debt noncash investing or financing activities. Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Warrants exercised, minimum percent of outstanding shares, to receive cash Warrants Exercised, Minimum Percent Of Outstanding Shares, To Receive Cash Warrants Exercised, Minimum Percent Of Outstanding Shares, To Receive Cash Amount of loan drawn Proceeds from Issuance of Secured Debt Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number Deferred payroll tax, current portion Accrued Payroll Taxes, Current Research and development Research and Development Expense Purchase of short-term investments (certificates of deposit) Payments to Acquire Short-Term Investments Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Paycheck Protection Program Paycheck Protection Program [Member] Represents the information pertaining to Paycheck Protection Program. Effective tax rate Effective Income Tax Rate Reconciliation, Percent Alpha Healthcare Acquisition Corp. and Hunter Merger Sub, Inc. Alpha Healthcare Acquisition Corp. and Hunter Merger Sub, Inc. [Member] Represents the information pertaining to Alpha Healthcare Acquisition Corp. and Hunter Merger Sub, Inc. Grant Revenue Revenue From Grants [Member] Revenue From Grants Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Number of equity incentive plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans The number of plans in share-based compensation arrangement. Number of shares, vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Reverse Recapitalization Business Combination Disclosure [Text Block] Other income (expense), net: Other Nonoperating Income (Expense) [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Prime Rate Prime Rate [Member] Risk concentration Concentration Risk, Percentage Number of tranches Debt Instrument, Number of Tranches The number of tranches of loan release in a loan agreement. Weighted average expected share price volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Income Taxes Income Tax Disclosure [Text Block] Summary of common stock reserved for future issuances Schedule of Common Stock Reserved For Future Issuance [Table Text Block] The tabular disclosure of common stock were reserved for future issuance. SVB loan payable Secured Long-Term Debt, Noncurrent Warrants, exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest on SVB loan Interest Paid, Excluding Capitalized Interest, Operating Activities Number of contingent earnout shares per tranche (in shares) Reverse Recapitalization, Contingent Consideration, Liability, Shares Per Tranche The number of shares of combined entity per tranche that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Net income (loss) per share attributable to common stockholders, basic (in dollars per share) Net income (loss) attributable to common shareholders - basic (in dollars per share) Earnings Per Share, Basic Decellularized Tissue Engineering Patent Rights Decellularized Tissue Engineering Patent Rights [Member] Decellularized Tissue Engineering Patent Rights Common Stock Warrants Warrants And Rights Outstanding, Policy [Policy Text Block] Warrants And Rights Outstanding, Policy Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Stock Option Plan, 2005 Stock Option Plan, 2005 [Member] Represents 2005 Stock Option plan. Dividends, common stock Dividends, Common Stock Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Entity Interactive Data Current Entity Interactive Data Current Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Share accepting a tender offer entitles warrants to receive cash (as a percent) Class of Warrant or Right, Redemption Threshold The percentage of outstanding shares that accept a tender or exchange offer made that triggers entitles holders to receive cash for all warrants. Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Summary of Changes in Fair Value of Level 3 Financial Instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Cash equivalents (money market funds) Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Unrecognized share-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Common Stock Common Stock [Member] Summary of Stock-Based Compensation Expense and Remaining Unrecognized Costs Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of reportable segment Number of Reportable Segments Number of shares remaining available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Contingent Earnout Liability Business Combination, Contingent Consideration, Liability Class of Stock [Axis] Class of Stock [Axis] Statement [Table] Statement [Table] Cash, cash equivalents, and short-term investments Cash, Cash Equivalents, and Short-Term Investments Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Document Quarterly Report Document Quarterly Report Public Warrants Public Warrants [Member] Represents the information pertaining to Public Warrants. Assets assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Furniture and fixtures Furniture and Fixtures [Member] Current assets Assets, Current [Abstract] Number of trading days Reverse Recapitalization, Contingent Consideration, Liability, Stock Price Trigger, Number Of Trading Days The number of days that volume-weighted average closing sale price of stock within 30 day period that triggers the earnout shares of combined entity for former holders of acquiree stocks Operating lease obligation, net of current portion Operating Lease, Liability, Noncurrent Omnibus Incentive Plan, 2015 Omnibus Incentive Plan, 2015 [Member] Represents 2015 Omnibus Incentive Plan. Schedule of assumptions used in the valuations Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Final payment amount of SVB loan payable Debt Instrument, Final Payment Amount Final payment amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Related Party Transaction [Axis] Related Party Transaction [Axis] Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Debt Instrument, Prepayment Fee, Period [Axis] Debt Instrument, Prepayment Fee, Period [Axis] Debt Instrument, Prepayment Fee, Period Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Proceeds from PIPE Proceeds from Issuance of Private Placement Recurring Fair Value, Recurring [Member] Related Party Transactions Related Party Transactions Disclosure [Text Block] Weighted average exercise price, vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Segments Segment Reporting, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Warrants term Warrants and Rights Outstanding, Term Payment of finance lease principal Finance Lease, Principal Payments Term Loan Agreement Term Loan Agreement [Member] Represents the information pertaining to term loan agreement. Legacy Humacyte common stock conversion ratio to common stock Recapitalization Exchange Ratio The conversion ratio of the acquiree's common stock to the combined entity's common stock. Total other income, net Nonoperating Income (Expense) Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Long-Term Incentive Plan, 2021 Long-Term Incentive Plan, 2021 [Member] Represents the 2021 Long-Term Incentive Plan. Series A preferred stock Series A Preferred Stock [Member] Weighted average exercise price, vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report AHAC AHAC [Member] AHAC Local Phone Number Local Phone Number Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Loss from operations Operating losses Operating Income (Loss) Debt Instrument, Prepayment Fee, Period Two Debt Instrument, Prepayment Fee, Period Two [Member] Debt Instrument, Prepayment Fee, Period Two Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Milestone payments Collaborative Arrangement, Milestone Payments Represents the amount of milestone payments upon achievement of certain regulatory milestones. Document Information [Table] Document Information [Table] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding License expenses License Expenses [Member] Represents the information pertaining to License expenses. Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Less redemption of AHAC shares (in shares) Stock Repurchased During Period, Shares Number of consecutive trading days Reverse Recapitalization, Contingent Consideration, Liability, Stock Price Trigger, Number of Consecutive Trading Day Period The period over which the number of days that volume-weighted average closing sale price of stock that triggers the earnout shares of combined entity for former holders of acquiree stocks. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax expense or benefit Income Tax Expense (Benefit) Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Government Contracts Concentration Risk Government Contracts Concentration Risk [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Number of vote per common share held Common Stock, Number of Votes Per Unit Of Shares Held Represents the number of vote per common share held. Series B preferred stock Series B Preferred Stock [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) Weighted-average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average expected share price volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Outstanding principal and interest collateralized Debt Instrument, Percent of Collateral Amount in Outstanding Principal and Interest Percent of amount to be collateralized in outstanding principal and interest. Earnings Per Share, Basic and Diluted [Abstract] Earnings Per Share, Basic And Diluted, EPS [Abstract] Earnings Per Share, Basic And Diluted, EPS Expected term of options (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Conversion of redeemable convertible preferred stock into common stock in connection with the Merger and related PIPE financing (in shares) Stock Issued During Period, Shares, Conversion, Merger and Related PIPE Financing The number of stock issued during the period for conversion of common stock in connection with the Merger and related PIPE financing. Accounts Receivable Accounts Receivable [Member] Schedule of Reverse Recapitalization [Line Items] Schedule of Reverse Recapitalization [Line Items] Schedule of Reverse Recapitalization [Line Items] Common stock, $0.0001 par value; 250,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 103,006,803 and 103,003,646 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Summary of securities that could potentially dilute net loss per share in the future that were not included in the computation of diluted net loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Aggregate intrinsic value, vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Liabilities: Financial Liabilities Fair Value Disclosure [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Private Placement Private Placement [Member] Preferred stock, shares designated (in shares) Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Warrants, measurement input Warrants and Rights Outstanding, Measurement Input Market price of public stock Current stock price Measurement Input, Share Price [Member] Current liabilities Liabilities, Current [Abstract] Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Common stock, shares issued (in shares) Common stock issued (in shares) Common Stock, Shares, Issued Contingent earnout liability recognized upon the closing of the reverse capitalization Reverse Recapitalization, Contingent Consideration, Liability Recognized Amount of contingent consideration liability recognized upon the closing of the reverse recapitalization. Weighted average remaining contractual term, vested and expected to vest (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Concentration Risk [Line Items] Concentration Risk [Line Items] Purchase of property and equipment in accounts payable Capital Expenditures Incurred but Not yet Paid Proceeds from SVB loan Proceeds from Bank Debt Common stock warrant liabilities Private Placement Warrants liability Warrants and Rights Outstanding Income Statement Location [Domain] Income Statement Location [Domain] Finance lease obligation, current portion Finance Lease, Liability, Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Exercise price Measurement Input, Exercise Price [Member] Capital Shares Reserved for Future Issuance [Domain] Capital Shares Reserved for Future Issuance [Domain] Information on capital stock reserved for future issuance. Transaction costs expensed (less than) Professional Fees Maximum loan facility amount Debt Instrument, Face Amount Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P., Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P., [Member] Represents the information pertaining to Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P.,. Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Entity Current Reporting Status Entity Current Reporting Status Assumption Of Publicly Traded Securities Assumption Of Publicly Traded Securities [Member] Assumption Of Publicly Traded Securities Future minimum payments of principal and estimated payments of interest Long-Term Debt, Fiscal Year Maturity [Abstract] Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Number of shares, vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Closing trading price per share of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Common Shareholders Common Shareholders [Member] Common Shareholders Summary of Related Party Expenses Schedule of Related Party Transactions [Table Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Outstanding awards (in shares) Options outstanding, beginning of period (in shares) Options outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Net premium associated with accretion of final payment and other debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Basis of Presentation and Unaudited Interim Condensed Consolidated Financial Statements Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Change in fair value included in other income, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Exercise of options under stock plan Options Share-Based Payment Arrangement, Option [Member] Weighted average expected share price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Transaction costs Transaction Costs for Raising Capital Amount of transaction costs for raising capital. Advance notice period Debt Instrument, Advance Notice Period N/A Proceeds from the exercise of stock options Stock Issued During Period, Value, Stock Options Exercised SVB loan payable, current and noncurrent Long-Term Debt Balance Sheet Location [Axis] Balance Sheet Location [Axis] Price per share (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common stock, authorized (in shares) Common Stock, Shares Authorized Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Statement of Comprehensive Income [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Operating Expenses Maximum Maximum [Member] Annual increase in available shares Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Annual Increase, Percent The annual increase of shares reserve for the share-based compensation plans as percent of the lesser of the number of shares of the entity's common stock outstanding on calendar year end of the preceding year and a number of shares of common stock determined by the Company's board of directors. Regulatory Milestone Regulatory Milestone [Member] Regulatory Milestone Accrued external research, development and manufacturing costs Accrued External Research Development And Manufacturing Costs, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for external research, development, and manufacturing expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Maximum annual maintenance fee Collaborative Arrangement, Maximum Annual Maintenance Fee Represents the amount of maximum annual maintenance fee. Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Schedule of activity of warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Stockholders' Equity (Deficit) Stockholders' Equity Note Disclosure [Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Non-cash operating lease costs Operating Lease, Right-of-Use Asset, Amortization Expense Line of Credit Facility [Table] Line of Credit Facility [Table] Contingent Consideration Tranches [Domain] Contingent Consideration Tranches [Domain] Contingent consideration tranches number. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Amortization of SVB debt discount Amortization of Debt Discount (Premium) Aggregate intrinsic value, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Short-term investments Short-Term Investments Conversion of stock (in shares) Conversion of Stock, Shares Issued Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 [Member] Information pertaining to redeemable warrants exercisable for common stock. Final payment fee percentage Debt Instrument, Final Payment Fee, Percent Represents the percentage of final payment fee. Expected share price volatility Measurement Input, Price Volatility [Member] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Small-Diameter Vessels Patent Rights Small-Diameter Vessels Patent Rights [Member] Small-Diameter Vessels Patent Rights Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] 2022 (remainder) Long-Term Debt, Maturity, Remainder of Fiscal Year Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Aggregate purchase price Sale of Stock, Consideration Received on Transaction Tranche two Contingent Consideration Tranche Two [Member] Represents the information pertaining to contingent consideration tranche two. Accounts payable Accounts Payable, Current Aggregate intrinsic value, vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Warrants to purchase common stock Warrant [Member] Entity Filer Category Entity Filer Category Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic (in shares) Weighted-average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Accrued Liabilities, Current [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Expense Supplemental disclosure of noncash activities: Noncash Investing and Financing Items [Abstract] Commitments and contingencies (Note 11) Commitments and Contingencies Security Exchange Name Security Exchange Name Options outstanding, beginning of period (in dollars per share) Options outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Issuance of common stock upon reverse recapitalization and PIPE Financing (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Preferred stock, $0.0001 par value; 20,000,000 shares designated as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued Capital Shares Reserved for Future Issuance [Axis] Capital Shares Reserved for Future Issuance [Axis] The table relating to information on capital stock reserved for future issuance. Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative General and Administrative Expense [Member] Reserved common stock for future issuances (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cash and Cash Equivalents Cash and Cash Equivalents [Member] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Certificates of deposit Certificates of Deposit, at Carrying Value Stock-based Compensation Share-Based Payment Arrangement [Text Block] Debt Instrument, Prepayment Fee, Period Three Debt Instrument, Prepayment Fee, Period Three [Member] Debt Instrument, Prepayment Fee, Period Three Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total liabilities and stockholders’ equity Liabilities and Equity Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Debt issuance costs Amortization of Debt Issuance Costs Related Party [Axis] Related Party [Axis] Warrants exercised (in shares) Number of Warrants Exercised Number of warrants exercised. Dilutive effect of assumed conversion of options to purchase common stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Level 2 Fair Value, Inputs, Level 2 [Member] Tranche one Contingent Consideration Tranche One [Member] Represents the information pertaining to contingent consideration tranche one. Current Fiscal Year End Date Current Fiscal Year End Date Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) Net income (loss) attributable to common shareholders - diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Payment of deferred offering costs Payments of Stock Issuance Costs Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of common stock warrant liabilities Change in fair value of common stock warrant liabilities Fair Value Adjustment of Warrants Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Unpaid deferred offering costs Deferred Offering Costs Incurred But Not Yet Paid Deferred Offering Costs Incurred But Not Yet Paid Exercisable warrants upon funding of additional tranche (in shares) Class of Warrant or Right, Exercisable Upon Funding of Additional Tranche Number of warrants that becomes exercisable upon borrowing an additional loan tranche in a loan agreement. Reverse Recapitalization [Abstract] Reverse Recapitalization Entity Ex Transition Period Entity Ex Transition Period Contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Entity Address, Address Line One Entity Address, Address Line One New Humacyte shares issued in Merger to Legacy Humacyte stockholders (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Schedule of Common Stock Outstanding Immediately Following the Consummation of the Merger Schedule of Common Stock Outstanding Immediately Following the Consummation of the Merger [Table Text Block] Tabular disclosure of common stock outstanding immediately following the consummation of the Merger. Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Fair Value Disclosures [Abstract] Interest expense Interest Expense Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Equity [Abstract] Summary of SVB Loan Payable and Net Discount or Premium Balances Schedule of Long-Term Debt Instruments [Table Text Block] Commercial Milestone Commercial Milestone [Member] Commercial Milestone Entity Tax Identification Number Entity Tax Identification Number Asset Acquisition [Line Items] Asset Acquisition [Line Items] Changes in the fair value of the Level 3 financial instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Accrued Liabilities Accrued Liabilities [Member] Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Interest income Investment Income, Interest Measurement Frequency [Axis] Measurement Frequency [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Measurement Input Type [Axis] Measurement Input Type [Axis] Entity [Domain] Entity [Domain] Duke University Duke University [Member] Represents the pertaining information of duke university. City Area Code City Area Code Accrued professional fees Accrued Professional Fees, Current General and administrative General and Administrative Expense ASSETS Assets [Abstract] Common stock reserved for Contingent Earnout Shares Common stock reserved for Contingent Consideration Shares [Member] Represents the information pertaining to common stock reserved for Contingent Consideration Shares. Accrued Expenses Accrued Liabilities Disclosure [Text Block] The entire disclosure for Accrued Liabilities Disclosure of financial statements disclosure. Shares available for grant under ESPP Shares available for grant under ESPP [Member] Represents the information pertaining to shares available for grant under ESPP. Statement of Stockholders' Equity [Abstract] Termination period Collaborative Arrangement, Termination Period Represents the threshold notice period required to terminate the agreement. Sale of Stock [Axis] Sale of Stock [Axis] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Total financial liabilities Financial Liabilities Fair Value Disclosure Net Loss per Share Attributable to Common Stockholders Earnings Per Share, Policy [Policy Text Block] 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Warrants (in shares) Class of Warrant or Right, Outstanding Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Prepayment fee Debt Instrument, Prepayment Fee, Percent Debt Instrument, Prepayment Fee, Percent Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Issuance of warrants in conjunction with debt Adjustments to Additional Paid in Capital, Warrant Issued In Conjunction With Debt Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants in conjunction with allocation of proceeds of debt securities issued with detachable stock purchase warrants. Redeemable convertible preferred stock Redeemable Convertible Preferred Stock [Member]